Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge

The antimalarial hydroxychloroquine (HCQ) has demonstrated several crucial properties for the treatment of systemic lupus erythematosus (SLE). Herein, we reviewed the main HCQ pharmacologic features, detailed its mechanism of action, and summarized the existing guidelines and recommendations for HCQ...

Descripción completa

Detalles Bibliográficos
Autores principales: Dima, Alina, Jurcut, Ciprian, Chasset, François, Felten, Renaud, Arnaud, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848057/
https://www.ncbi.nlm.nih.gov/pubmed/35186126
http://dx.doi.org/10.1177/1759720X211073001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848057/
https://www.ncbi.nlm.nih.gov/pubmed/35186126
http://dx.doi.org/10.1177/1759720X211073001

Ejemplares similares